Exhibit 99.2
CRANE CO.
Income Statement Data
(in thousands, except per share data)
| | | | | | | | |
| | Three Months Ended March 31, | |
| | 2006 | | | 2005 | |
Net Sales: | | | | | | | | |
Aerospace & Electronics | | $ | 142,440 | | | $ | 133,581 | |
Engineered Materials | | | 85,950 | | | | 80,798 | |
Merchandising Systems | | | 52,557 | | | | 43,753 | |
Fluid Handling | | | 245,348 | | | | 228,552 | |
Controls | | | 23,243 | | | | 20,516 | |
Intersegment Elimination | | | (155 | ) | | | (139 | ) |
| | | | | | | | |
Total Net Sales | | $ | 549,383 | | | $ | 507,061 | |
| | | | | | | | |
Operating Profit: | | | | | | | | |
Aerospace & Electronics | | $ | 22,474 | | | $ | 15,950 | |
Engineered Materials | | | 15,739 | | | | 16,858 | |
Merchandising Systems | | | 3,752 | | | | 3,781 | |
Fluid Handling | | | 24,356 | | | | 12,424 | |
Controls | | | 2,592 | | | | 1,759 | |
Corporate | | | (11,698 | ) | | | (8,922 | ) |
| | | | | | | | |
Total Operating Profit | | | 57,215 | | | | 41,850 | |
| | |
Interest Income | | | 708 | | | | 341 | |
Interest Expense | | | (5,527 | ) | | | (5,720 | ) |
Miscellaneous- Net | | | 1,261 | | | | 282 | |
| | | | | | | | |
Income Before Income Taxes | | | 53,657 | | | | 36,753 | |
Provision for Income Taxes | | | 16,258 | | | | 11,755 | |
| | | | | | | | |
Net Income | | $ | 37,399 | | | $ | 24,998 | |
| | | | | | | | |
Share Data: | | | | | | | | |
Net Income Per Diluted Share | | $ | 0.61 | | | $ | 0.42 | |
| | | | | | | | |
Average Diluted Shares Outstanding | | | 61,801 | | | | 60,070 | |
Average Basic Shares Outstanding | | | 60,718 | | | | 59,455 | |
| | |
Supplemental Data: | | | | | | | | |
Cost of Sales | | $ | 371,501 | | | $ | 351,641 | |
Selling, General & Administrative | | | 120,667 | | | | 113,570 | |
Depreciation and Amortization * | | | 15,265 | | | | 12,344 | |
Stock Compensation Expense | | | 4,082 | | | | 2,953 | |
* | Amount included within cost of sales and selling, general & administrative costs. |
CRANE CO.
Condensed Balance Sheets
(in thousands)
| | | | | | |
| | March 31, 2006 | | December 31, 2005 |
ASSETS | | | | | | |
Current Assets | | | | | | |
Cash and Cash Equivalents | | $ | 96,501 | | $ | 180,392 |
Accounts Receivable | | | 315,063 | | | 289,521 |
Inventories | | | 284,884 | | | 272,354 |
Other Current Assets | | | 58,610 | | | 56,128 |
| | | | | | |
Total Current Assets | | | 755,058 | | | 798,395 |
| | |
Property, Plant and Equipment | | | 265,104 | | | 263,791 |
Insurance Receivable - Asbestos | | | 222,833 | | | 224,600 |
Other Assets | | | 315,842 | | | 284,345 |
Goodwill | | | 608,535 | | | 568,355 |
| | | | | | |
Total Assets | | $ | 2,167,372 | | $ | 2,139,486 |
| | | | | | |
LIABILITIES AND SHAREHOLDERS’ EQUITY | | | | | | |
Current Liabilities | | | | | | |
Notes Payable and Current Maturities of Long-Term Debt | | $ | 189 | | $ | 254 |
Accounts Payable | | | 150,690 | | | 149,647 |
Current Asbestos Liability | | | 55,000 | | | 55,000 |
Accrued Liabilities | | | 167,870 | | | 174,366 |
Income Taxes | | | 24,135 | | | 19,322 |
| | | | | | |
Total Current Liabilities | | | 397,884 | | | 398,589 |
| | |
Long-Term Debt | | | 293,616 | | | 293,248 |
Deferred Tax Liability | | | 73,306 | | | 71,406 |
Long-Term Asbestos Liability | | | 515,762 | | | 526,830 |
Other Liabilities | | | 96,989 | | | 96,119 |
Shareholders’ Equity | | | 789,815 | | | 753,294 |
| | | | | | |
Total Liabilities and Shareholders’ Equity | | $ | 2,167,372 | | $ | 2,139,486 |
| | | | | | |
CRANE CO.
Condensed Statements of Cash Flows
(in thousands)
| | | | | | | | |
| | Three Months Ended March 31, | |
| | 2006 | | | 2005 | |
Operating Activities: | | | | | | | | |
Net income | | $ | 37,399 | | | $ | 24,998 | |
Income from joint venture | | | (1,761 | ) | | | (1,198 | ) |
Depreciation and amortization | | | 15,265 | | | | 12,344 | |
Stock-based compensation expense | | | 4,082 | | | | 2,953 | |
Cash used for operating working capital | | | (32,899 | ) | | | (45,021 | ) |
Other | | | 4,196 | | | | 978 | |
| | | | | | | | |
Subtotal | | | 26,282 | | | | (4,946 | ) |
Payments for asbestos-related fees and costs, net | | | (9,300 | ) | | | (10,824 | ) |
Refund associated with terminated Master Settlement Agreement | | | — | | | | 9,925 | |
| | | | | | | | |
Total provided by (used for) operating activities | | | 16,982 | | | | (5,845 | ) |
| | | | | | | | |
Investing Activities: | | | | | | | | |
Capital expenditures | | | (8,390 | ) | | | (5,575 | ) |
Proceeds from disposition of capital assets | | | 1,236 | | | | 255 | |
Payment for acquisition, net of cash acquired | | | (85,338 | ) | | | — | |
| | | | | | | | |
Total used for investing activities | | | (92,492 | ) | | | (5,320 | ) |
| | | | | | | | |
Financing Activities: | | | | | | | | |
Dividends paid | | | (7,623 | ) | | | (5,955 | ) |
Common shares acquired on the open market | | | (12,041 | ) | | | — | |
Stock options exercised - net of shares reacquired | | | 8,396 | | | | 1,761 | |
Excess tax benefit from stock-based compensation | | | 1,716 | | | | — | |
Repayment of debt, net | | | (202 | ) | | | (1,684 | ) |
| | | | | | | | |
Total used for financing activities | | | (9,754 | ) | | | (5,878 | ) |
| | | | | | | | |
Effect of exchange rate on cash and cash equivalents | | | 1,373 | | | | (1,107 | ) |
| | | | | | | | |
Decrease in cash and cash equivalents | | | (83,891 | ) | | | (18,150 | ) |
Cash and cash equivalents at beginning of period | | | 180,392 | | | | 50,727 | |
| | | | | | | | |
Cash and cash equivalents at end of period | | $ | 96,501 | | | $ | 32,577 | |
| | | | | | | | |
CRANE CO.
Order Backlog
(in thousands)
| | | | | | | | | |
| | March 31, 2006 | | December 31, 2005 | | March 31, 2005 |
Aerospace & Electronics | | $ | 364,539 | | $ | 365,010 | | $ | 367,472 |
Engineered Materials | | | 16,972 | | | 17,241 | | | 19,414 |
Merchandising Systems | | | 14,838 | | | 9,183 | | | 9,469 |
Fluid Handling | | | 205,741 | | | 188,832 | | | 200,578 |
Controls | | | 19,480 | | | 16,864 | | | 15,625 |
| | | | | | | | | |
Total Backlog | | $ | 621,570 | | $ | 597,130 | | $ | 612,558 |
| | | | | | | | | |
CRANE CO.
Non-GAAP Financial Measures
(in thousands)
| | | | | | | | |
| | March 31, 2006 | | | December 31, 2005 | |
BALANCE SHEET ITEMS | | | | | | | | |
Notes Payable and Current Maturities of Long-Term Debt | | $ | 189 | | | $ | 254 | |
Long-Term Debt | | | 293,616 | | | | 293,248 | |
| | | | | | | | |
Total Debt | | | 293,805 | | | | 293,502 | |
Less Cash and Cash Equivalents | | | (96,501 | ) | | | (180,392 | ) |
| | | | | | | | |
Net Debt | | | 197,304 | | | | 113,110 | |
Shareholders’ Equity | | | 789,815 | | | | 753,294 | |
| | | | | | | | |
Total Capitalization | | $ | 987,119 | | | $ | 866,404 | |
| | | | | | | | |
Percentage of Net Debt to Total Capitalization | | | 20.0 | % | | | 13.1 | % |
| | | | | | | | | | | | |
| | Three Months Ended March 31, | | | Year Ended December 31, | |
| | 2006 | | | 2005 | | | 2006 | |
| | | | | | | | (Estimated) | |
CASH FLOW ITEMS | | | | | | | | | | | | |
Cash Provided from (Used by) Operating Activities before Asbestos - Related Payments | | $ | 26,282 | | | ($ | 4,946 | ) | | $ | 260,000 | |
Net Asbestos Payments * | | | (9,300 | ) | | | (10,824 | ) | | | (45,000 | ) |
Refund Associated with Terminated Master Settlement Agreement | | | — | | | | 9,925 | | | | — | |
| | | | | | | | | | | | |
Cash Provided from (Used by) Operating Activities | | | 16,982 | | | | (5,845 | ) | | | 215,000 | |
Less: Capital Expenditures | | | (8,390 | ) | | | (5,575 | ) | | | (30,000 | ) |
| | | | | | | | | | | | |
Free Cash Flow | | $ | 8,592 | | | ($ | 11,420 | ) | | $ | 185,000 | |
| | | | | | | | | | | | |
* | Includes certain legal fees and expenses relating to the terminated Master Settlement Agreement amounting to $5.1 million in 2005, of which $3.6 million was incurred in the first quarter of 2005. |
Certain | non-GAAP measures have been provided to facilitate comparison with the prior year. |
Free cash flow provides supplemental information to assist management and investors in analyzing the Company’s ability to generate positive cash flow. Free cash flow is considered a measure of cash generation and should be considered in addition to, but not as a substitute for, other measures reported in accordance with generally accepted accounting principles and may be inconsistent with similar measures presented by other companies.